Correlation Between HCW Biologics and Biora Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Biora Therapeutics, you can compare the effects of market volatilities on HCW Biologics and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Biora Therapeutics.
Diversification Opportunities for HCW Biologics and Biora Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Biora is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Biora Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Biora Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 6.69 times more return on investment than Biora Therapeutics. However, HCW Biologics is 6.69 times more volatile than Biora Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Biora Therapeutics is currently generating about -0.33 per unit of risk. If you would invest 53.00 in HCW Biologics on August 26, 2024 and sell it today you would earn a total of 24.00 from holding HCW Biologics or generate 45.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Biora Therapeutics
Performance |
| Timeline |
| HCW Biologics |
| Biora Therapeutics |
HCW Biologics and Biora Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Biora Therapeutics
The main advantage of trading using opposite HCW Biologics and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Biora Therapeutics vs. Eliem Therapeutics | Biora Therapeutics vs. HCW Biologics | Biora Therapeutics vs. Scpharmaceuticals | Biora Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |